Modulation of microRNA associated with ovarian cancer cells by genistein

L. P. Parker, D. D. Taylor, Joshua Kesterson, D. S. Metzinger, C. Gercel-Taylor

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Purpose: Role of microRNAs in malignancies is well established due their regulatory role in cellular differentiation, proliferation and cell cycle control. Our purpose was to determine miRNA profiles of serially established ovarian cancer cell lines and the effect of genistein treatment. Methods: Cell lines (UL-3A, UL-3B) were established from one patient during progression of disease. miRNA profiling was performed in untreated and genistein-treated cells. Estrogen receptors (ER) were studied with real-time polymerase chain reaction (RT-PCR) and Western immunoblotting. In vitro migration and invasion assays were utilized. Results: While 108 miRNAs were expressed equally in both cell lines and their genistein-treated counterparts, an additional 53 miRNAs were differentially expressed. Genistein resulted in induction of ERα and ERβ in ovarian cancer cells. A significant reduction in migration and invasion of UL-3A and UL-3B was demonstrated in genistein-treated cells. Conclusion: Common and unique miRNA profiles were demonstrated between the two cell lines, some of which were altered by genistein.

Original languageEnglish (US)
Pages (from-to)616-621
Number of pages6
JournalEuropean Journal of Gynaecological Oncology
Volume30
Issue number6
StatePublished - Dec 7 2009

Fingerprint

Genistein
MicroRNAs
Ovarian Neoplasms
Estrogen Receptors
Cell Line
Cell Cycle Checkpoints
Disease Progression
Real-Time Polymerase Chain Reaction
Western Blotting
Cell Proliferation
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynecology

Cite this

Parker, L. P., Taylor, D. D., Kesterson, J., Metzinger, D. S., & Gercel-Taylor, C. (2009). Modulation of microRNA associated with ovarian cancer cells by genistein. European Journal of Gynaecological Oncology, 30(6), 616-621.
Parker, L. P. ; Taylor, D. D. ; Kesterson, Joshua ; Metzinger, D. S. ; Gercel-Taylor, C. / Modulation of microRNA associated with ovarian cancer cells by genistein. In: European Journal of Gynaecological Oncology. 2009 ; Vol. 30, No. 6. pp. 616-621.
@article{0a3e1fa7558744ff8971afd92cb218f2,
title = "Modulation of microRNA associated with ovarian cancer cells by genistein",
abstract = "Purpose: Role of microRNAs in malignancies is well established due their regulatory role in cellular differentiation, proliferation and cell cycle control. Our purpose was to determine miRNA profiles of serially established ovarian cancer cell lines and the effect of genistein treatment. Methods: Cell lines (UL-3A, UL-3B) were established from one patient during progression of disease. miRNA profiling was performed in untreated and genistein-treated cells. Estrogen receptors (ER) were studied with real-time polymerase chain reaction (RT-PCR) and Western immunoblotting. In vitro migration and invasion assays were utilized. Results: While 108 miRNAs were expressed equally in both cell lines and their genistein-treated counterparts, an additional 53 miRNAs were differentially expressed. Genistein resulted in induction of ERα and ERβ in ovarian cancer cells. A significant reduction in migration and invasion of UL-3A and UL-3B was demonstrated in genistein-treated cells. Conclusion: Common and unique miRNA profiles were demonstrated between the two cell lines, some of which were altered by genistein.",
author = "Parker, {L. P.} and Taylor, {D. D.} and Joshua Kesterson and Metzinger, {D. S.} and C. Gercel-Taylor",
year = "2009",
month = "12",
day = "7",
language = "English (US)",
volume = "30",
pages = "616--621",
journal = "European Journal of Gynaecological Oncology",
issn = "0392-2936",
publisher = "S.O.G. CANADA Inc.",
number = "6",

}

Parker, LP, Taylor, DD, Kesterson, J, Metzinger, DS & Gercel-Taylor, C 2009, 'Modulation of microRNA associated with ovarian cancer cells by genistein', European Journal of Gynaecological Oncology, vol. 30, no. 6, pp. 616-621.

Modulation of microRNA associated with ovarian cancer cells by genistein. / Parker, L. P.; Taylor, D. D.; Kesterson, Joshua; Metzinger, D. S.; Gercel-Taylor, C.

In: European Journal of Gynaecological Oncology, Vol. 30, No. 6, 07.12.2009, p. 616-621.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Modulation of microRNA associated with ovarian cancer cells by genistein

AU - Parker, L. P.

AU - Taylor, D. D.

AU - Kesterson, Joshua

AU - Metzinger, D. S.

AU - Gercel-Taylor, C.

PY - 2009/12/7

Y1 - 2009/12/7

N2 - Purpose: Role of microRNAs in malignancies is well established due their regulatory role in cellular differentiation, proliferation and cell cycle control. Our purpose was to determine miRNA profiles of serially established ovarian cancer cell lines and the effect of genistein treatment. Methods: Cell lines (UL-3A, UL-3B) were established from one patient during progression of disease. miRNA profiling was performed in untreated and genistein-treated cells. Estrogen receptors (ER) were studied with real-time polymerase chain reaction (RT-PCR) and Western immunoblotting. In vitro migration and invasion assays were utilized. Results: While 108 miRNAs were expressed equally in both cell lines and their genistein-treated counterparts, an additional 53 miRNAs were differentially expressed. Genistein resulted in induction of ERα and ERβ in ovarian cancer cells. A significant reduction in migration and invasion of UL-3A and UL-3B was demonstrated in genistein-treated cells. Conclusion: Common and unique miRNA profiles were demonstrated between the two cell lines, some of which were altered by genistein.

AB - Purpose: Role of microRNAs in malignancies is well established due their regulatory role in cellular differentiation, proliferation and cell cycle control. Our purpose was to determine miRNA profiles of serially established ovarian cancer cell lines and the effect of genistein treatment. Methods: Cell lines (UL-3A, UL-3B) were established from one patient during progression of disease. miRNA profiling was performed in untreated and genistein-treated cells. Estrogen receptors (ER) were studied with real-time polymerase chain reaction (RT-PCR) and Western immunoblotting. In vitro migration and invasion assays were utilized. Results: While 108 miRNAs were expressed equally in both cell lines and their genistein-treated counterparts, an additional 53 miRNAs were differentially expressed. Genistein resulted in induction of ERα and ERβ in ovarian cancer cells. A significant reduction in migration and invasion of UL-3A and UL-3B was demonstrated in genistein-treated cells. Conclusion: Common and unique miRNA profiles were demonstrated between the two cell lines, some of which were altered by genistein.

UR - http://www.scopus.com/inward/record.url?scp=70949103350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70949103350&partnerID=8YFLogxK

M3 - Article

C2 - 20099489

AN - SCOPUS:70949103350

VL - 30

SP - 616

EP - 621

JO - European Journal of Gynaecological Oncology

JF - European Journal of Gynaecological Oncology

SN - 0392-2936

IS - 6

ER -